Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release
Product Images NDC 63629-9477

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release (NDC 63629-9477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amphetamine 01)

Figure 1 (Amphetamine 01)
The text provides a table indicating the plasma concentrations (in ng/mL) of dextro and levoamphetamine at different time intervals (8, 12, 16, 20, and 24 hours). The table also shows the medications used (Adderall and extended-release capsules) and their dosages (20mgqd and 10mg bid).*
FDA Label Image

Label (Lbl636299477)

Label (Lbl636299477)
This is a medication guide for NS dx3, which is a mixed Amphetamine Salts ER Capsule. Each capsule contains four ingredients that make up 6.3 mg of amphetamine base equivalence. It should be stored at temperatures between 20°C to 25°C (68°F to 77°F). Dispense in a tightly-closed, light-resistant container, and keep all medication out of reach of children. The NDC is 63629-9477-01, and 100 capsules are present in a tightly closed container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.